S1 Ep57: Pharmacy Focus Podcast: Psychedelic Pharmacy - Episode 2
In the second episode of the Psychedelic Pharmacy series, Payton Nyquvest, CEO and founder of Numinus, discussed the laboratory development and regulatory side of psychedelic research. In the interview, Nyquvest said he believes psychedelics will lead to a major shift in the mental health treatment paradigm in the next 3 to 5 years.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.